CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE267.304.2 (+1.6 %)
PREV CLOSE () 263.10
OPEN PRICE () 272.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 284645
TODAY'S LOW / HIGH ()265.90 275.45
52 WK LOW / HIGH ()217.5 307
NSE267.203.45 (+1.31 %)
PREV CLOSE() 263.75
OPEN PRICE () 271.90
BID PRICE (QTY) 267.20 (1300)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9499931
TODAY'S LOW / HIGH() 265.80 275.50
52 WK LOW / HIGH ()217.5 307.1
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1978

Management Info :

Kiran Mazumdar-Shaw - Chairman Siddharth Mittal - Managing Director

Registered Office :

Address : 20th Km,Hosur Road,Electronic City,
Bengaluru,
Karnataka-560100

Phone : 080 2808 2808

Website : www.biocon.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
18Apr Biocon, Aster DM Healthcare and Suntec
Biocon has signed an exclusive licensing and supply agreement with Biomm..
18Apr Biocon signs licensing and supply agre
Biocon has signed an exclusive licensing and supply agreement with Biomm..
18Apr Biocon shines on signing licensing and
Biocon is currently trading at Rs. 270.20, up by 7.10 points or 2.70% fr..
12Apr Biocon informs about updates
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..
03Apr Biocon’s arm transfers branded formula
Biocon’s subsidiary -- Biocon Biologics has completed the transaction of..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit24028484
Gross Profit 329 29712
Operating Profit 11982949
Net Sales 562819929
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
NGL Fine-Chem (BSE)
 2542.60 (12.29%)
M.Cap ( in Cr)
1570.82
Neuland Laboratories (BSE)
 7654.80 (1.79%)
M.Cap ( in Cr)
9821.02
Mankind Pharma (BSE)
 2397.40 (5.05%)
M.Cap ( in Cr)
96037.07
Sanofi India (BSE)
 8470.70 (0.89%)
M.Cap ( in Cr)
19508.55
Solara Active Pharma (BSE)
 474.10 (12.15%)
M.Cap ( in Cr)
1706.58
Shareholding Pattern
PROMOTERS 60.64%
NON-INSTITUTION 20.05%
MUTUAL FUNDS/UTI 8.57%
FI/BANKS/INSURANCE 5.02%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX72488.99-454.69 (-0.62%)
NIFTY21995.85-152.05 (-0.69%)
Dow Jones 37753.31-45.66 (-0.12%)
Nasdaq 15683.37-181.88 (-1.15%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI